124 related articles for article (PubMed ID: 19501579)
1. Chitotriosidase determination in plasma and in dried blood spots: a comparison using two different substrates in a microplate assay.
Rodrigues MD; de Oliveira AC; Müller KB; Martins AM; D'Almeida V
Clin Chim Acta; 2009 Aug; 406(1-2):86-8. PubMed ID: 19501579
[TBL] [Abstract][Full Text] [Related]
2. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of Gaucher patients with a novel chitotriosidase assay.
Schoonhoven A; Rudensky B; Elstein D; Zimran A; Hollak CE; Groener JE; Aerts JM
Clin Chim Acta; 2007 Jun; 381(2):136-9. PubMed ID: 17408605
[TBL] [Abstract][Full Text] [Related]
4. Blood spot versus plasma chitotriosidase: a systematic clinical comparison.
Elmonem MA; Ramadan DI; Issac MS; Selim LA; Elkateb SM
Clin Biochem; 2014 Jan; 47(1-2):38-43. PubMed ID: 24177195
[TBL] [Abstract][Full Text] [Related]
5. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak CE; van Weely S; van Oers MH; Aerts JM
J Clin Invest; 1994 Mar; 93(3):1288-92. PubMed ID: 8132768
[TBL] [Abstract][Full Text] [Related]
6. Common G102S polymorphism in chitotriosidase differentially affects activity towards 4-methylumbelliferyl substrates.
Bussink AP; Verhoek M; Vreede J; Ghauharali-van der Vlugt K; Donker-Koopman WE; Sprenger RR; Hollak CE; Aerts JM; Boot RG
FEBS J; 2009 Oct; 276(19):5678-88. PubMed ID: 19725875
[TBL] [Abstract][Full Text] [Related]
7. Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.
Irún P; Alfonso P; Aznarez S; Giraldo P; Pocovi M
Clin Biochem; 2013 Dec; 46(18):1804-7. PubMed ID: 24060732
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease.
Wajner A; Michelin K; Burin MG; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Biochem; 2007 Mar; 40(5-6):365-9. PubMed ID: 17291472
[TBL] [Abstract][Full Text] [Related]
9. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
Dodelson de Kremer R; Paschini de Capra A; Angaroni CJ; Giner de Ayala A
Medicina (B Aires); 1997; 57(6):677-84. PubMed ID: 9674188
[TBL] [Abstract][Full Text] [Related]
10. Screening of high-risk Gaucher disease patients in Brazil using miniaturized dried blood spots and leukocyte techniques.
Goldim MP; Garcia Cda S; de Castilhos CD; Daitx VV; Mezzalira J; Breier AC; Cé J; Mello A; Andrade CV; Sartori N; Coelho JC
Gene; 2012 Oct; 508(2):197-8. PubMed ID: 22884741
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases.
Wajner A; Michelin K; Burin MG; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Biochem; 2004 Oct; 37(10):893-7. PubMed ID: 15369720
[TBL] [Abstract][Full Text] [Related]
12. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers).
Giraldo P; Cenarro A; Alfonso P; Pérez-Calvo JI; Rubio-Félix D; Giralt M; Pocoví M
Haematologica; 2001 Sep; 86(9):977-84. PubMed ID: 11532627
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic analysis of biomarkers for the monitoring of Gaucher patients in Colombia.
Pacheco N; Uribe A
Gene; 2013 May; 521(1):129-35. PubMed ID: 23523857
[TBL] [Abstract][Full Text] [Related]
14. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper.
Olivova P; van der Veen K; Cullen E; Rose M; Zhang XK; Sims KB; Keutzer J; Browning MF
Clin Chim Acta; 2009 May; 403(1-2):159-62. PubMed ID: 19245803
[TBL] [Abstract][Full Text] [Related]
15. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
[TBL] [Abstract][Full Text] [Related]
16. Plasmalogen levels in Gaucher disease.
Moraitou M; Dimitriou E; Zafeiriou D; Reppa C; Marinakis T; Sarafidou J; Michelakakis H
Blood Cells Mol Dis; 2008; 41(2):196-9. PubMed ID: 18501647
[TBL] [Abstract][Full Text] [Related]
17. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV
Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855
[TBL] [Abstract][Full Text] [Related]
18. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots.
Eyles D; Anderson C; Ko P; Jones A; Thomas A; Burne T; Mortensen PB; Nørgaard-Pedersen B; Hougaard DM; McGrath J
Clin Chim Acta; 2009 May; 403(1-2):145-51. PubMed ID: 19232332
[TBL] [Abstract][Full Text] [Related]
19. Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots.
Gasparotto N; Tomanin R; Frigo AC; Niizawa G; Pasquini E; Blanco M; Donati MA; Keutzer J; Zacchello F; Scarpa M
Clin Chim Acta; 2009 Apr; 402(1-2):38-41. PubMed ID: 19111682
[TBL] [Abstract][Full Text] [Related]
20. Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch.
Auwerda JJ; Leebeek FW; Wilson JH; van Diggelen OP; Lam KH; Sonneveld P
Transfusion; 2006 Oct; 46(10):1705-11. PubMed ID: 17002626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
